Zobrazeno 1 - 10
of 109
pro vyhledávání: '"PG Subramanian"'
Autor:
Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 10, Iss 1, Pp e2018002-e2018002 (2018)
Atypical breakpoints and variant APL cases involving alternative chromosomal aberrations are seen in a small subset of acute promyelocytic leukemia (APL) patients. Over 7 different partner genes for RARA have been described. Although rare, these vari
Externí odkaz:
https://doaj.org/article/f2941ce1cc0c4f9bae94a9605c0abcae
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Srinivasan, Shyam, Dhamne, Chetan, Moulik, Nirmalya Roy, Bhat, Vasudev, Shetty, Dhanlaxmi, Tembhare, Prashant, Patkar, Nikhil, PG, Subramanian, Narula, Gaurav, Banavali, Shripad
Publikováno v:
In Pediatric Hematology Oncology Journal 2019 4(2) Supplement:S35-S35
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S Gujral, S Polampalli, Y Badrinath, A Kumar, A Chogule, PG Subramanian, G Raje, P Amare, B Arora, SD Banavali, CN Nair
Publikováno v:
Indian journal of cancer. 46(2)
Background : We present a clinico-hematological profile and treatment outcome of Biphenotypic Acute Leukemia (BAL). Aim : Study incidence and subtypes of BAL, correlate with age, morphology, and cytogenetic findings and correlate the clinico-hematolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc6102dde491acf70477c908fd4910c5
https://pubmed.ncbi.nlm.nih.gov/19346652
https://pubmed.ncbi.nlm.nih.gov/19346652
Autor:
Nikhil V Patkar, Prashant Deshpande, Russel Mascarenhas, PG Subramanian, Prashant Tembhare, Bhausaheb Bagal, Sumeet Gujral, Manju Sengar, Hari Menon
Publikováno v:
Blood. 122:4299-4299
Introduction Waldenstrom Macroglobulinemia (WM) harbors a mutation in MYD88 gene (MYD88L265P) with frequencies varying from 67% to 91%. Although of diagnostic use its clinical significance in terms of prognosis and treatment response is unclear. We r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec7ddb9e930bbc239150f6906b586cb1
https://doi.org/10.1182/blood.v122.21.4299.4299
https://doi.org/10.1182/blood.v122.21.4299.4299
Autor:
PG Subramanian
Publikováno v:
The Indian Journal of Medical Research. 135:12
Chronic myeloid leukaemia (CML) is a clonal stem cell disorder characterized by increased proliferation of myeloid lineage. CML is the commonest adult leukaemia in India and the annual incidence ranges from 0.8–2.2/100,000 population in males and 0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b69499d76d00c0fe7b7ad4b2eb282270
https://doi.org/10.4103/0971-5916.93418
https://doi.org/10.4103/0971-5916.93418
Autor:
Roy Moulik N; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Keerthivasagam S; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.; Jawaharlal Institute of Postgraduate Medical Education and Research, Medical Oncology, Puducherry, India., Chatterjee G; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Hematopathology, Mumbai, India., Agiwale J; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Rane P; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Biostatistics, Mumbai, India., Dhamne C; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Chichra A; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Srinivasan S; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Mohanty P; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Cancer Cytogenetics, Mumbai, India., Jain H; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Cancer Cytogenetics, Mumbai, India., Shetty D; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Cancer Cytogenetics, Mumbai, India., Rajpal S; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Hematopathology, Mumbai, India., Tembhare P; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Hematopathology, Mumbai, India., Patkar N; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Hematopathology, Mumbai, India., Narula G; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Subramanian PG; Homi Bhabha National Institute, Mumbai, India.; Tata Memorial Hospital, Hematopathology, Mumbai, India., Banavali S; Tata Memorial Hospital, Pediatric Oncology, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.